Comparison of 18 F-AlF-NOTA-PRGD2 and 18 F-FDG PET/CT Imaging in a Case of Primary Uveal Melanoma.

Clin Nucl Med

Department of Ophthalmology, Jiangnan University Medical Center JUMC, Wuxi No. 2 People's Hospital, Wuxi, Jiangsu Province, China.

Published: May 2024

AI Article Synopsis

  • Uveal melanoma is the most common eye cancer in adults, known for its high rates of spreading and mortality.
  • The study examined two types of PET/CT imaging—18 F-AlF-NOTA-PRGD2 and 18 F-FDG—used on a patient with primary uveal melanoma.
  • Results showed that both imaging methods detected increased radioactive uptake in tumor lesions, with 18 F-AlF-NOTA-PRGD2 showing significantly higher uptake than 18 F-FDG.

Article Abstract

Uveal melanoma is the most common intraocular malignancy in adults with a high rate of metastasis and mortality. This study presented the PET/CT imaging of 18 F-AlF-NOTA-PRGD2 and 18 F-FDG in a patient with primary uveal melanoma. In addition to fundus photograph and ophthalmic ultrasonography, both 18 F-AlF-NOTA-PRGD2 and 18 F-FDG PET/CT imaging showed increased radioactive uptake in the lesions within the scan area. The tumoral lesions presented significantly higher uptake of 18 F-AlF-NOTA-PRGD2 compared with that of 18 F-FDG.

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000005143DOI Listing

Publication Analysis

Top Keywords

f-alf-nota-prgd2 f-fdg
12
pet/ct imaging
12
uveal melanoma
12
f-fdg pet/ct
8
primary uveal
8
comparison f-alf-nota-prgd2
4
f-fdg
4
imaging case
4
case primary
4
melanoma uveal
4

Similar Publications

Ultrasensitive detection of uveal melanoma using [F]AlF-NOTA-PRGD2 PET imaging.

EJNMMI Res

July 2024

NHC Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, 214063, Jiangsu Province, China.

Background: Uveal melanoma (UM) is the most common primary intraocular tumor in adults, and early detection is critical to improve the clinical outcome of this disease. In this study, the diagnostic effectiveness of [F]AlF-NOTA-PRGD2 (an investigational medicinal product) positron emission tomography (PET) imaging in UM xenografts and UM patients were evaluated. The cell uptake, cell binding ability and in vitro stability of [F]AlF-NOTA-PRGD2 were evaluated in 92-1 UM cell line.

View Article and Find Full Text PDF

Comparison of 18 F-AlF-NOTA-PRGD2 and 18 F-FDG PET/CT Imaging in a Case of Primary Uveal Melanoma.

Clin Nucl Med

May 2024

Department of Ophthalmology, Jiangnan University Medical Center JUMC, Wuxi No. 2 People's Hospital, Wuxi, Jiangsu Province, China.

Article Synopsis
  • Uveal melanoma is the most common eye cancer in adults, known for its high rates of spreading and mortality.
  • The study examined two types of PET/CT imaging—18 F-AlF-NOTA-PRGD2 and 18 F-FDG—used on a patient with primary uveal melanoma.
  • Results showed that both imaging methods detected increased radioactive uptake in tumor lesions, with 18 F-AlF-NOTA-PRGD2 showing significantly higher uptake than 18 F-FDG.
View Article and Find Full Text PDF

This study aimed to stereotactically compare the PET imaging performance of (18)F-Alfatide ((18)F-ALF-NOTA-PRGD2, denoted as (18)F-Alfatide) and (18)F-fluorodeoxyglucose (FDG) and immunohistochemistry (IHC) staining in Lewis lung carcinoma (LLC) tumor-bearing C57BL/6 mouse model. (18)F-FDG standard uptake values (SUVs) were higher than (18)F-Alfatide SUVs in tumors, most of the normal tissues and organs except for the bladder. Tumor-to-brain, tumor-to-lung, and tumor-to-heart ratios of (18)F-Alfatide PET were significantly higher than those of (18)F-FDG PET (P < 0.

View Article and Find Full Text PDF

Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model.

Nucl Med Commun

September 2015

aPET/CT of Imaging Department, Sichuan Cancer Hospital bNational Engineering Research Center for Biomaterials cDepartment of Radiology, West China Hospital, Sichuan University, Chengdu dThe Third People's Hospital of Chengdu, Chengdu eWuxi Molecular Imaging CRO Co. Ltd, Wuxi, People's Republic of China.

Objective: (18)F-Fluorodeoxyglucose ((18)F-FDG), (18)F-fluoro-3'-deoxy-3'-L-fluorothymidine ((18)F-FLT), (18)F-fluoromisonidazole ((18)F-FMISO), and (18)F-AlF-NOTA-PRGD2 ((18)F-RGD) are all commonly used PET tracers for tumor diagnosis based on different mechanisms of tissue uptake. This study compared the ex-vivo biodistribution and PET/computed tomography (CT) imaging studies of these four PET tracers in a xenograft prostate tumor-bearing mouse model.

Materials And Methods: Nude mice were inoculated with 5 × 10 PC-3 cells in the right armpit.

View Article and Find Full Text PDF

First experience of 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination.

J Nucl Med

May 2013

Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, China.

Unlabelled: (18)F-FPPRGD2, which was approved for clinical study recently, has favorable properties for integrin targeting and showed potential for antiangiogenic therapy and early response monitoring. However, the time-consuming multiple-step synthesis may limit its widespread applications in the clinic. In this study, we developed a simple lyophilized kit for labeling PRGD2 peptide ((18)F-AlF-NOTA-PRGD2, denoted as (18)F-alfatide) using a fluoride-aluminum complex that significantly simplified the labeling procedure.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!